MAM
FSTX
Morse Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-42,935
| Closed | -$148K | – | 144 |
|
|
2019
Q3 | $148K | Buy |
42,935
+30,900
| +257% | +$107K | 0.06% | 121 |
|
|
2019
Q2 | $44K | Sell |
12,035
-137,140
| -92% | -$501K | 0.01% | 131 |
|
|
2019
Q1 | $1.57M | Sell |
149,175
-19,525
| -12% | -$205K | 0.47% | 60 |
|
|
2018
Q4 | $1.75M | Sell |
168,700
-21,350
| -11% | -$222K | 0.62% | 47 |
|
|
2018
Q3 | $2.29M | Buy |
190,050
+12,550
| +7% | +$151K | 0.6% | 51 |
|
|
2018
Q2 | $2.1M | Buy |
177,500
+11,725
| +7% | +$139K | 0.58% | 50 |
|
|
2018
Q1 | $2.49M | Buy |
165,775
+18,900
| +13% | +$284K | 0.69% | 47 |
|
|
2017
Q4 | $1.82M | Buy |
146,875
+22,875
| +18% | +$284K | 0.51% | 58 |
|
|
2017
Q3 | $2M | Buy |
124,000
+60,300
| +95% | +$975K | 0.6% | 59 |
|
|
2017
Q2 | $862K | Buy |
63,700
+38,900
| +157% | +$526K | 0.28% | 79 |
|
|
2017
Q1 | $223K | Buy |
+24,800
| New | +$223K | 0.08% | 125 |
|